Shares of XOMA (XOMA) are active this morning, jumping +13.6% on heavy volume after a bullish...


Shares of XOMA (XOMA) are active this morning, jumping +13.6% on heavy volume after a bullish article in Seeking Alpha said that with recent management changes the company is better positioned than anytime before to stage a comeback. In addition to new management, its key anti-inflammatory drug, Gevokizumab, is also in Phase III trials and looks very encouraging for wide array of applications.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs